BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21592456)

  • 41. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease.
    Sebro R; Aparici CM; Hernandez-Pampaloni M
    Ann Nucl Med; 2013 May; 27(4):400-5. PubMed ID: 23400394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
    Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    Suh YJ; Park CM; Han K; Jeon SK; Kim H; Hwang EJ; Lee JH; Paeng JC; Lee CH; Kim YT; Goo JM
    AJR Am J Roentgenol; 2020 Mar; 214(3):514-523. PubMed ID: 31846374
    [No Abstract]   [Full Text] [Related]  

  • 45. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation of radiographically indeterminate solitary pulmonary nodules with.
    Hung GU; Shiau YC; Tsai SC; Ho YJ; Kao CH; Yen RF
    Jpn J Clin Oncol; 2001 Feb; 31(2):51-4. PubMed ID: 11302341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Jul; 23(5):427-35. PubMed ID: 19437097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
    Chen S; Li X; Chen M; Yin Y; Li N; Li Y
    Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
    Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy of F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scans in diagnosis of pulmonary nodules].
    Orino K; Kawamura M; Hatazawa J; Suzuki I; Sazawa Y
    Jpn J Thorac Cardiovasc Surg; 1998 Dec; 46(12):1267-74. PubMed ID: 10037834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is
    Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
    Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic accuracy of semiquantitative analysis of positron emission tomography in radiologically indeterminate lung lesions].
    Ruiz-Hernández G; González A; de Juan R; Verea H; Callol LM; Domper M; Suárez M; Lapeña L; Montz R; Carreras Delgado JL
    Rev Esp Med Nucl; 2002; 21(6):403-9. PubMed ID: 12425887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
    van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
    J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.
    Brocken P; van der Heijden HF; Dekhuijzen PN; Peters-Bax L; de Geus-Oei LF
    Respiration; 2014; 87(1):32-7. PubMed ID: 23595051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.
    Hellwig D; Gröschel A; Graeter TP; Hellwig AP; Nestle U; Schäfers HJ; Sybrecht GW; Kirsch CM
    Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):13-21. PubMed ID: 16151765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
    Yap CS; Czernin J; Fishbein MC; Cameron RB; Schiepers C; Phelps ME; Weber WA
    Chest; 2006 Feb; 129(2):393-401. PubMed ID: 16478857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X; Guo Y; Qian X
    Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Hales NW; Krempl GA; Medina JE
    Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.